Qube Research & Technologies LTD Atri Cure, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Atri Cure, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 31,198 shares of ATRC stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,198
Previous 51,191
39.06%
Holding current value
$1.02 Million
Previous $1.65 Million
38.1%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATRC
# of Institutions
224Shares Held
52.2MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.91MShares$161 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$151 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$130 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY3.57MShares$117 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$100 Million1.62% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.52B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...